Showing posts with label Eli Lilly. Show all posts
Showing posts with label Eli Lilly. Show all posts

Side Effects: Death: A Former Lilly Insider Explains How the Big Pharma Criminal Cartel Operates






Background


'John Virapen is now retired, after working more than 30 years in the pharma industry internationally. He has worked at the executive level for some major companies such as Eli Lilly and Novo Nordisk. His career started in Sweden where he was Managing Director for Eli Lilly Sweden AB. Virapen now lives in Germany.

Last year Virapen published a fictional novel (written in German) about corruption in the pharma industry, which created some debate. He was urged by the public to tell the true story and has now written a book of memoirs primarily outlining the criminal activities he was involved in during his active years.

The Big Fish here is Eli Lilly. A few months ago Virapen was invited by Andy Vickery, a prominent US attorney, as a fact witness in an ongoing case regarding Prozac. Virapen claims to have "damning evidence" exposing Eli Lilly bribing the regulatory board in Sweden to attain marketing approval for Prozac.

In this podcast, Virapen will reveal some of the details of this ongoing expose that few in the US are aware of.'

Note: "Side Effects: Death" is available in English at Amazon.

What Big Pharma Knows – “Side Effects: Death”

'Many of the horrific school, workplace and mass shootings that have plagued parts of the world over the years may not have occurred if the pharmaceutical industry had been completely honest about the side effects of psychotropic medication, according to the new book Side Effects: Death – Confessions of a Pharma Insider by former executive director of the Swedish Branch of Eli Lilly & Company John Virapen.

Virapen claims that anti-depressants and selective serotonin reuptake inhibitors (SSRIs) were known to have suicidal and homicidal side effects, even during clinical trials. Thanks to spin marketing and paid, positive articles in scientific journals, he points out, the adverse reactions were often ignored or given little thought by prescribing physicians and patients.

Virapen also asserts the pharmaceutical industry has engaged in bribery and other major forms of corruption to gain approval for and in the marketing of many drugs used to treat such conditions as Attention Deficit Hyperactivity Disorder (ADHD), schizophrenia, arthritis, pain, diabetes and many others. The industry also “makes up” illnesses to enhance sales and market shares, he says.

To boost sales, Virapen writes, large pharmaceutical corporations spend about $35,000–$40,000 per year and per practicing doctor to persuade them to prescribe their products. In addition to covering or “massaging”
the negative effects of drugs, many of the companies engage in “off-label marketing,” which encourages physicians to prescribe the medicines for conditions for which they haven’t been approved, Virapen reveals.

Born in British Guyana, John Virapen went from a door-to-door conman to a pop star, to a pharmaceutical representative to executive director of one of the largest drug companies in the world. He admits to participating in bribery, false information and deception to help launch and market some of the most popularly prescribed (and most dangerous) drugs. In an effort to exorcise his demons and expose the tactics and dangers of the pharmaceutical industry, he wrote this expose.

The book has been published in four languages around the world and is a best-seller in Europe.'


Original HERE and HERE
>>>READ MORE

Lilly: "I were referred to me as person who specializes in pharmaceutical based informatics and wanted to reach out to me."

At "What, Me Worry? Lilly Fined Over Zyprexa, Should Be Fined For eRecruitment Inanity As Well?", I wrote about a very bizarre eRecruiting message I received from Eli Lilly:

In just about the most bizarre and inane recruiting email I think I've ever received, this unsolicited gem came in to my professional email account. This is at least the second time I received this identical message in the past few weeks.

It began with "Dear MD." Click on the above link to see that solicitation.

I didn't think it could get much worse than that.

I was wrong.

This just in, exactly as received (emphases mine):

From: Hank Gehron
Sent: Tue, 3 Mar 2009 7:45 am
Subject: Your Help Is Requested for a Eli Lilly Career Opportunity! (Discovery Informatics Director at Indianapolis)


I am a member of the Staffing Team at Eli Lilly. I were referred to me as person who specializes in pharmaceutical based informatics. I wanted to reach out to me, to see if you maybe able to recommend anyone that could qualify for the below position.

[Perhaps I should recommend my grade school English teacher to go over this solicitation with a big red marking pencil? - ed.]

For more than 130 years, Eli Lilly and Company has been dedicated to meeting the health care needs of people in the United States and around the world. We address these needs primarily by developing innovative medicines-investing a higher percentage of our sales in research and development than any other major pharmaceutical company. If you are interested in being considered for employment with a "Best in Class" Pharmaceutical company, please review the following opportunity.

Please feel free to call me with any questions; or perhaps you may know of someone that could qualify.

Your consideration is most appreciated.

Hank Gehron, MBA, SPHR
Lilly Talent Acquisition Team / RightThing Recruiting Process Outsourcing
work. 610-263-3030 Ext. 4450, Country Code 001
blackberry. 610-836-1856
hank.gehron@rightthinginc.com

Then there are the "requirements":

MINIMUM REQUIREMENTS:
M.S. or Ph.D. in Biology, Chemistry, or related Computational sciences
Minimum of 8-10 years experience in biotech or pharma industry
Minimum of 3-5 years managing/leading Informatics teams
Strong understanding of genomic, proteomic, expression, and imaging platforms.
Experience in the specifications, design, development, and deployment of bioinformatics, chemo-informatics, and translational informatics tools and analysis to support research portfolio.

Note no call for formal medical or medical informatics training, as this position is not really "Discovery Informatics" (which would encompass medical informatics), it is primarily bioinformatics or "gene stuff." I commented on that field at "Has Bioinformatics Hit a Hard Wall of Stagnation?" here.

I will not comment further, only asking a simple question:

Is this a company you would want to work for or that inspires confidence in its ability to produce safe medicines?


What? Me worry about talking good with grammar?


-- SS

>>>READ MORE

What, Me Worry? Lilly Fined Over Zyprexa, Should Be Fined For eRecruitment Inanity As Well?

In a story of a type all too familiar to HC Renewal readers, Eli Lilly & Co. on Thursday reached a deal to pay $1.4 billion and plead guilty to a federal misdemeanor charge over promoting an antipsychotic drug to treat dementia when it wasn't approved to do so. This involved promotion for use in the elderly including nursing home patients. "5 at 5" (for "5 mg at 5 PM to keep the sundowning at bay") was the sales pitch.

Lilly will take a reputational hit as a result, although like the Ford Pinto (a.k.a. "the barbecue that seats four") this minor cost of doing business (and the patient harm done) is, in the calculus of modern business, outweighed by the margins they attained for this activity.

Zyprexa's brought in more than $37 billion in sales for Eli Lilly since its U.S. approval in 1996, according to calculations made by The Wall Street Journal.


Here's my take on this from an entirely different angle. Perhaps the following email helps explain why the company lacked people on board who might have prevented this debacle.

In just about the most bizarre and inane recruiting email I think I've ever received, this unsolicited gem came in to my professional email account. This is at least the second time I received this identical message in the past few weeks:

To: (MedInformaticsMD)
From: Candidate Care [candidatecare@rightthinginc.com]
Date: 01/16/2009 06:34AM
Subject: Job Opportunity - Lilly

Dear MD,

I am a member of the Staffing Team at Lilly and I am writing to express my interest in your background and skills in regards to a position with our company.

At Lilly , we are looking for candidates who meet a specific and unique skill set. I feel that you may be this type of candidate and would like to discuss this opportunity with you further, and I encourage you to visit our website at https://jobs.lilly.com/index.cfm for more information. Lilly offers very competitive salary and benefit packages, commensurate with skills and experience.

Once you are at this website please select the category and what type of work you might be interested in. You can then select the position of interest and review the specific information about your potential new career

Applying online for this position would be a great first step. Shortly after you apply, someone from our staffing team will contact you to discuss next steps and provide you with more information.

Thank you for your time. I will monitor our database for your submittal and ensure you are contacted soon after.

Sincerely,

Lilly , Talent Acquisition Team

Please do not reply to this email


Problems I see:

1. Dear "MD"

Dear MD? How so very personalized and suggestive that this company values people. Perhaps, as in the recent U.S presidential election, it could simply address potential candidates as "that one?"

2. "I am a member of the Staffing Team at Lilly and I am writing to express my interest in your background and skills in regards to a position with our company"

"I" am a member? Who are you? What is your name? Are you with RightThingInc.Com (apparently some sort of eRecruitment outsourcing company -ed.) or Lilly? What do you mean by "A position?"

I'm listening, but ...

3. "At Lilly , we are looking for candidates who meet a specific and unique skill set. I feel that you may be this type of candidate and would like to discuss this opportunity with you further."

What specific and unique skill set? What "opportunity?" The link that was sent seems to be some sort of tracked hyperlink that merely sends me to Lilly's general eRecruiting site and search tools. If you mouse over the deceptive "https://jobs.lilly.com/index.cfm" hyperlink in the email it appears to contain some type of unmentioned, embedded tracking data for purposes unknown:

http://www.netrecruit.net/cgi-bin/CloakTrkr.pl?_siteGuid=spartner
&_smhid=2000961039010&_isa=Recruiter&_isaID=69481630
&oemID=RTI_1084&_redirencoded=https%3A%2F%2Fjobs.lilly.com
%2Findex.cfm&_txt=https%3A%2F%2Fjobs.lilly.com%2Findex.cfm


4. "Once you are at this website please select the category and what type of work you might be interested in. You can then select the position of interest and review the specific information about your potential new career."

Select "the" position of interest? The position of interest to whom? Them, or me? Is this a guessing game of some type? Find the hidden treasure? What the hell are they talking about? Did the person who wrote this speak English? Did they have a brain?

5. "Applying online for this position would be a great first step. Shortly after you apply, someone from our staffing team will contact you to discuss next steps ..."

Oh, really? How about if I apply for CEO? For Janitor? (or, how about Chief Corporate Honesty Officer?)

6. "Thank you for your time. I will monitor our database for your submittal and ensure you are contacted soon after." -- Lilly, Talent Acquisition Team

And who, exactly, are you, Mr. or Ms. T. A. Team? Perhaps your name is "HAL?"

7. "Please do not reply to this email"

Consider this post my reply.

HAL, will I also have to take some moronic online personality assessment test? And by the way, could you please open the pod bay doors?

Seriously, I've been involved in recruitment and hiring in both industry (hospital, pharma) and academia. This Lilly email has truly hit a new low for inanity, misuse of information technology, and more seriously the utter destruction of my ability to take a company that would issue such a message, or hire a contractor who did so, seriously.

I'm sure many smart and competent people of integrity would feel likewise.

It's likely hard to get good talent to prevent debacles over drugs when you present your company to the world in this manner.


What, me worry? Zyprexa is good for 'dem gorked out old fogies!


Additional thought: speaking of talent management, was anyone dismissed over the push to market Zyprexa for off-label use in dementia? If not, why not?

-- SS
>>>READ MORE